News Releases

News Releases

  • Jul 12, 2017

    Summary ToggleCo-Diagnostics, Inc. Announces Pricing of IPO

    Co-Diagnostics, Inc. (NASDAQ: CODX) (“Co-Diagnostics” or the “Company”), a molecular diagnostics company that has developed and intends to manufacture and sell reagents used for diagnostic tests, announced today that its initial public offering of 1,178,532 shares of common stock has been priced at